Potential biomarkers in early arthritis include differential infiltration by CD22+ve B cells and CD38+ plasma cells in patients with early arthritis differentiating RA vs. non RA inflammatory arthritis (40). The gene discussed is CD22; the disease is rheumatoid arthritis.